Search Results
State of the ART: Integrase Inhibitors Resistance | Charles Boucher, MD, PhD
Resistance to Integrase Inhibitors | Charles Boucher, MD, PhD
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhD
Resistance Characteristics of Integrase Inhibitors | Jonathan Schapiro, MD
The Integrase Inhibitors drug class: a comparative clinical review | Ian Frank
Basic Science of Integrase Inhibitors | Mark Wainberg, MD
Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD
State of the Art: Resistance to INSTI | Anne-Geneviève Marcelin, PharmD, PhD,
Optimizing Clinical Utility of Integrase Inhibitors | Anton Pozniak, MD, FRCP
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Session 2: Reduced Drug Regimens: Scientific Considerations | Full Livestream
